| Literature DB >> 31920407 |
Nikola Schütz1, Dominik Roth1, Michael Schwameis1, Martin Röggla1, Hans Domanovits1.
Abstract
OBJECTIVE: Blood gas analysis plays an important role in both diagnosis and subsequent treatment of critically ill patients in the emergency department and the ICU. Historically, arterial blood is predominantly used for blood gas analysis. The puncture is painful and complications may occur. The purpose of the present study was to evaluate the agreement between arterial and venous blood gas analysis and whether the sole use of venous blood gas analysis would have changed therapy.Entities:
Keywords: blood gas analysis; intubation; questionnaire; venous and arterial blood sampling
Year: 2019 PMID: 31920407 PMCID: PMC6934126 DOI: 10.2147/OAEM.S228420
Source DB: PubMed Journal: Open Access Emerg Med ISSN: 1179-1500
Questionnaire
| Questions | Physician No. 1 | Physician No. 1 |
|---|---|---|
| Would the respirator have been adjusted? | Yes/No | Yes/No |
| If yes: Measures to increase or decrease the respiratory minute volume? | ||
| If yes: Measures to improve the oxygenation or to reduce the pO2? | ||
| Would the tube position have been checked? | Yes/No | Yes/No |
| Is there a metabolic acidosis? | Yes/No | Yes/No |
| Does it require treatment? | Yes/No | Yes/No |
| Is there a lactic acidosis? | Yes/No | Yes/No |
| Is there a ketoacidosis? | Yes/No | Yes/No |
| Would you suspect uremia? | Yes/No | Yes/No |
| Is there a metabolic alkalosis? | Yes/No | Yes/No |
| Does it require treatment? | Yes/No | Yes/No |
| Would you suspect that a specific toxicologic problem is present? (eg. salicylates, ethylene glycol, methyl alcohol) | Yes/No | Yes/No |
| Does this meet the criteria of hypocapnia/hypercapnia which has to be treated (eg. by modification of ventilation settings) immediately? | Yes/No | Yes/No |
Questionnaire Answered “Yes”
| Arterial | Venous"yes" | Sensitivity | Specificity | PPV | NPV | |
|---|---|---|---|---|---|---|
| Resp. adjustment? | 37 | 42 | 91.89% | 38.46% | 80.95% | 62.50% |
| Change RMV? | 22 | 28 | 86.36% | 67.85% | 67.85% | 86.36% |
| Change FiO2 or PEEP? | 26 | 30 | 80% | 56.52% | 66.66% | 72.22% |
| Tube position? | 5 | 6 | 80% | 95.55% | 66.66% | 97.72% |
| Met. acidosis? | 31 | 27 | 80.64% | 89.47% | 92.59% | 73.91% |
| Requires treatment? | 2 | 2 | 100% | 100% | 100% | 100% |
| Lactic acidosis? | 27 | 19 | 70.37% | 100% | 100% | 74.19% |
| Ketoacidosis? | 1 | 1 | 100% | 100% | 100% | 100% |
| Acidosis due to AKI? | 6 | 5 | 83.33% | 100% | 100% | 97.72% |
| Met. alkalosis? | 9 | 9 | 100% | 100% | 100% | 100% |
| Requires treatment? | 0 | 0 | / | 100% | / | 100% |
| Toxicologic problem? | 1 | 1 | 100% | 100% | 100% | 100% |
| Hyper/Hypocapnia? | 22 | 28 | 86.36% | 67.85% | 67.85% | 86.36% |
Note: "/" displays that PPV and Sensitivity cannot be calcluated due to n=0.
Baseline Characteristics of the Study Cohort
| N=50 | |
|---|---|
| Sex (female) | 19 (38%) |
| Age Median (IQR25/75; min–max) | 63 (49/69.75; 25–90) |
| Diagnosis (n; %) | CPR (22; 44%) |
| Respiratory insufficiency (6; 12%) | |
| Myocardial infarction (6; 12%) | |
| Epilepsy (4; 8%) | |
| Intracranial hemorrhage (3; 6%) | |
| pO2 arterial Median (IQR25/75; min–max) | 127 (96.17/264.25; 57.5–626) |
| Mean systolic blood pressure (SD; min–max) | 125 (42; 70–351) |
| Mean Respiratory Minute Volume (SD; min–max) | 7.17 (2.21; 1.1–12.4) |
| Mean Tidal volume (SD; min–max) | 517 (91; 291–845) |
| Mean PEEP (SD; min–max) | 6 (2.3; 4–15) |
| Mean SpO2 (IQR25/75; min–max) | 100 (97/100; 83–100) |
| Mean respiratory frequency (SD; min–max) | 14,8 (2.78; 4–22) |
| Mean FiO2 (SD; min–max) | 59 (23; 21–100) |
| Mean heart rate (SD; min–max) | 80.04 (19.16; 40–120) |
| Signs of aspiration | No (40; 80%) |
| Yes (8; 16%) | |
| Unclear (2; 4%) | |
| Correct tube position on admission | Yes (41; 82%) |
| No (9; 18%) |
Abbreviations: CPR, cardiopulmonary resuscitation; SD, standard deficiency; PEEP, positive end expiratory pressure.
Figure 1Bland–Altman pH. Squares represent individual measurements.
Abbreviations: LOA, limits of agreement; art, arterial; ven, venous.
Figure 2Bland–Altman pCO2. Squares represent individual measurements.
Abbreviations: LOA, limits of agreement; art, arterial; ven, venous.
Venous and Arterial Measurements
| Mean Arterial (SD; Min–Max) or Median (IQR25/75; Min–Max) | Mean Venous (SD; Min–Max) or Median (IQR25/75; Min–Max) | Mean Difference Art – Ven | Limits of Agreement | % Within the Set Limits | |
|---|---|---|---|---|---|
| pH | 7.253 (0.153; 6.812–7.501) | 7.23 (0.144; 6.776–7.465) | 0.02312 | −0.048 to 0.094 | 66% |
| BE | −5.094 (6.339; −24.3–9.7) mmol/l | −4,5(−7.95/-0.475; −26.1–10.7) mmol/l | −0.154 mmol/l | −3.7 to 3.4mmol/l | 92% |
| pCO2 | 49.002 (12.38; 26.6–90.5) mmHg | 52.614 (12.92; 31.5–95) mmHg | −3.612 mmHg | −15 to 8.1 mmHg | 52% |
| HCO3- | 19.794 (5.349; 6.2–33.1) mmol/l | 19.456 (5.33; 5.1–34.2) mmol/l | 0.338 mmol/l | −2.27 to 2.9 mmol/l | 92% |
| Lactate | 2.85 (1.525/7.175; 0.3–14.7) mg/dl | 3.45 (1.925/6.75; 0.2–14.4) mg/dl | −0.124 mg/dl | −2.28 to 2.03 mg/dl | 96% |
Figure 3Bland–Altman lactate. Squares represent individual measurements.
Abbreviations: LOA, limits of agreement; art, arterial; ven, venous.